Skip to main content
. Author manuscript; available in PMC: 2019 Jun 25.
Published in final edited form as: Eur J Med Chem. 2018 May 12;154:367–391. doi: 10.1016/j.ejmech.2018.04.062

Table 4.

Sensitivity of mutated-pseudoviruses to the NBD compounds

Substitutions 48
IC50 (μM)
39
IC50 (μM)
55
IC50 (μM)
BMS-626529
IC50 (nM)
Location
HIV-1HXB2 WT 0.36±0.01 0.15±0.01 0.13±0.003 ~8 -
L116P 0.54±0.05 0.15±0.005 0.14±0.001 >1000 CD4 binding site
A204D 0.52±0.05 0.87±0.2 0.65±0.05 >1000 V2
S375H 0.40±0.01 0.31±0.01 0.14±0.002 >1000 CD4 binding site
S375W 0.63±0.03 0.17±0.03 0.13±0.001 >1000 CD4 binding site
S375Y 0.44±0.01 0.3±0.01 0.19±0.02 >1000 CD4 binding site
I424F 0.55±0.01 1.3±0.5 0.88±0.1 >1000 CD4 binding site
N425K 1.5±0.1 0.37±0.03 0.18±0.03 ~8 CD4 binding site
M426L 0.49±0.01 0.14±0.001 0.12±0.001 230±10 CD4 binding site
M434I 0.97±0.1 0.25±0.04 0.23±0.01 ~8 CD4 binding site
F468L 0.24±0.05 0.14±0.01 0.12±0.006 ~8 V5
M434I/I595F 0.3±0.02 0.16±0.01 0.12±0.001 ~8 CD4 binding site/gp41
M475I 0.59±0.01 0.13±0.01 0.11±0.01 ~50 CD4 binding site

The reported IC50 values represent the means ± standard deviation (n = 3).